Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • ERS Guidelines
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Subscriptions

Bacterial profile and antibiotic susceptibility from patients with exacerbation of COPD: 10 – years prospective study

Nelya Bissenova, Aigerim Yergaliyeva
European Respiratory Journal 2016 48: PA2617; DOI: 10.1183/13993003.congress-2016.PA2617
Nelya Bissenova
1Department of Microbiology, National Scientific Medical Research Center, Astana, Kazakhstan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Aigerim Yergaliyeva
1Department of Microbiology, National Scientific Medical Research Center, Astana, Kazakhstan
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Background: Exacerbations are a major cause of treatment of COPD patients for medical care. The ground for the appointment of antibacterial drugs for these patients is the leading role of bacterial factor.We aimed to study bacterial landscape and antibiotic susceptibility of sputum from patients with exacerbation of COPD.

Materials and Methods: The microbiologic screening results of sputum 531 patients with exacerbation of COPD hospitalized at National Scientific Medical Center during 2004-2013 were prospectively analyzed.

Results: A total of 1210 isolates from these patients were included to the study. The most frequently pathogens were Streptococcus pneumoniae (27.9%) and Moraxella catarrhalis (20.1%). The prevalence of S.pneumoniae was increased from 18.1% in 2004 to 53.5% in 2013 (p<0.001). However, in should be noted decrease the detection rate of M.catarrhalis from 26.7% to 10.7% (p<0.001) respectively. Also were found S.aureus - 3,8%, P.aeruginosa - 2,1%, St,pyogenes - 7,9% Enterobacteriaceae - 3,5% of the total number of isolates. Study results showed a dynamic of decreasing antibiotic susceptibility of St.pneumoniae: to penicillin from 89.4% in 2004 to 46.1% in 2013 (p<0.001), to ceftiaxone from 96.4% to 69.5% (p<0.01), to cefotaxime from90.6% to 55.5% (p<0.02), to levofloxacin from 100% to 64% (p<0.001), and ciprofloxacin from 72% to 41.6% (p<0.05) respectively.

Conclusion: Constant microbiologic screening of patients with exacerbation of COPD, necessary to control the possible change of pathogens, as well as their level of antibiotic resistance. This leads to follow a strict policy on the use of antibiotics, which should be based on local data.

  • COPD - exacerbations
  • Infections
  • Treatments
  • Copyright ©the authors 2016
Previous
Back to top
Vol 48 Issue suppl 60 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Bacterial profile and antibiotic susceptibility from patients with exacerbation of COPD: 10 – years prospective study
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Bacterial profile and antibiotic susceptibility from patients with exacerbation of COPD: 10 – years prospective study
Nelya Bissenova, Aigerim Yergaliyeva
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2617; DOI: 10.1183/13993003.congress-2016.PA2617

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Bacterial profile and antibiotic susceptibility from patients with exacerbation of COPD: 10 – years prospective study
Nelya Bissenova, Aigerim Yergaliyeva
European Respiratory Journal Sep 2016, 48 (suppl 60) PA2617; DOI: 10.1183/13993003.congress-2016.PA2617
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Epidemiological and clinical features of non tuberculous mycobacteria infection (NTM) in a five-year single centre experience
  • A study of the relation of microbiological etiology with analytical and clinical parameters in exacerbation of COPD
  • Usefulness of real time-polymerase chain reaction (RT-PCR) in the diagnosis of ICU-acquired pneumonia (ICUAP)
Show more 10.1 Respiratory Infections

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2023 by the European Respiratory Society